The coping mechanism in lung neoplasma patients

C. Oancea (Dumbravita, Romania)

Source: International Congress 2017 – Miscellaneous clinical problems
Session: Miscellaneous clinical problems
Session type: Thematic Poster
Number: 3660

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Oancea (Dumbravita, Romania). The coping mechanism in lung neoplasma patients. 3660

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Religiosity and depression of patients with lung cancer
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011

The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Influence of the lung resection to sleep disorders in patients with lung cancer – pilot study on 10 patients
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008

Investigation of biomarkers for pulmonary carcinomatous lymphangitis in patients with lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Coping strategy influences quality of life in patients with advanced lung cancer
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019

Music prior to bronchoscopy reduces anxiety in patients with suspected lung cancer
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


Accompanying diseases in lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 127s
Year: 2006

Treatment choices in lung cancer patients with brain metastasis
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001

Some characteristics of empyema in lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 74s
Year: 2005

Microsatellite alterations in cell-free body fluids for the discrimination of lung cancer patients from patients with benign lung diseases
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008

How to treat lung cancer in IPF patients
Source: Research Seminar 2015
Year: 2015

Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

A study of the public‘s awareness of the causation of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 184s
Year: 2005

The role of bronchoscopy in the diagnosis of lung cancer and other diseases
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009

Features affecting stages of patients with lung cancer at diagnosis
Source: Eur Respir J 2005; 26: Suppl. 49, 536s
Year: 2005

Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


The relationship between hemoptysis and the features of tumors in primary lung cancer
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007


A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Outcomes of pulmonary rehabilitation after lung resection in patients with lung cancer
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021